Manufacturing
News and content about corporate responsibility innovations in the manufacturing industry.
POSTED
12-03-13
CSL Limited (ASX:CSL) publishes its fifth Corporate Responsibility Report
CSL Limited has published its fifth Corporate Responsibility Report - Our Corporate Responsibility 2013 - available at:
www.csl.com.au/corporate-responsibility.htm
The report details CSL’s performance...
POSTED
11-29-13
Novartis Foundation Launches New Leprosy Strategy at Symposium on Disease Elimination
Today’s symposium of the Novartis Foundation for Sustainable Development (NFSD) convenes experts to discuss “What does it take to eliminate a disease?” Drawing lessons from previous successful disease control programs, the symposium speakers discuss innovative approaches and advocate for new coor...
POSTED
11-29-13
Die Novartis Stiftung Lanciert Neue Leprastrategie an Ihrem Symposium über Krankheitseliminierung
Am heutigen Symposium der Novartis Stiftung für Nachhaltige Entwicklung (NFSD) diskutieren Experten über das Thema „Wie eliminiert man eine Krankheit?“ Ausgehend von Erfahrungen aus früheren erfolgreichen Programmen zur Krankheitsbekämpfung stellen die Referenten innovative Ansätze vor und treten...
POSTED
11-29-13
La Fondation Novartis Lance Une Nouvelle Stratégie de Lutte Contre la Lèpre Lors de son Symposium Sur L’élimination des Maladies
Le symposium de ce jour organisé par la Fondation Novartis pour un Développement Durable réunit des experts autour de la question suivante : « Comment éliminer une maladie ? » Tirant les enseignements de précédents programmes efficaces de lutte contre certaines maladies, les intervenants du sympo...
POSTED
11-29-13
New Malaria Target Identified With Potential to Prevent, Block and Treat Multiple Stages of the Malaria Life Cycle
Novartis scientists have discovered a new drug target for treating malaria. The discovery, which is published online in the journal Nature,2 identifies phosphatidylinositol-4 kinase (PfPI4K) as the target of the imidazopyrazines, a novel experimental antimalarial compound clas...
POSTED
11-29-13
Neues Malaria-Target mit dem Potenzial zur Prophylaxe, Hemmung und Behandlung verschiedener Stadien des Malarialebenszyklus identifiziert
Wissenschaftler von Novartis haben ein neues Wirkstoff-Target zur Behandlung von Malaria gefunden. Ihrer Entdeckung zufolge, die in Nature online publiziert wurde,2 fungiert die Phosphatidylinositol-4-Kinase (PfPI4K) als Target für Imidazopyrazine, eine neuartige, experimentel...
POSTED
11-29-13
Identification d'une nouvelle cible du paludisme ayant le potentiel de prévenir, bloquer et traiter plusieurs stades du cycle de vie du paludisme
Les chercheurs de Novartis ont découvert une nouvelle cible médicamenteuse pour le traitement du paludisme. La découverte, publiée en ligne dans la revue Nature,2 identifie phosphatidylinositol-4-kinase (PfPI4K) comme cible des imidazopyrazines, une nouvelle classe de molécule...
POSTED
11-21-13
What Does It Mean To Go the Extra Mile To Improve Access To Health?
The recent estimate from the International Diabetes Federation (IDF) Diabetes Atlas shows that globally 382 million people have diabetes, a figure that is equal to the combined population of the United States and United Kingdom. People living with diabetes in low- and middle-income countries make...
POSTED
11-18-13
P&G Releases Annual Sustainability Report; Announces Progress toward Environmental and Social Responsibility Goals for 2020
Procter & Gamble Company (NYSE:PG) today released its 15th annual Sustainability Report, demonstrating its commitment to helping people around the world live better and more sustainably through an integrated approach to environmental and social responsibility. The report includes P&G’s su...
POSTED
11-15-13
Novartis Honored with Outstanding Corporation Award by World Forum for Ethics in Business
The World Forum for Ethics in Business (WFEB) awarded Novartis the Ethics in Business Award in the Outstanding Corporation category. The WFEB is the public interest foundation focused on promoting and defending ethical approaches to business and corporate governance.
“This award recognizes...
